Who is sponsoring NCT03305094?

NCT03305094 is sponsored by Laval University.

What drugs are being tested in NCT03305094?

Interventions in NCT03305094: Blood pressure cuff inflation.

What condition does NCT03305094 study?

NCT03305094 studies Aortic Valve Stenosis, Cardiopulmonary Bypass.

Is NCT03305094 still recruiting?

NCT03305094 is currently status unknown. Last updated 10 March 2023.

Last reviewed 2023-03-10 · How we verify

NCT03305094

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Remote Ischemic Preconditioning in Aortic Valve Replacement Surgery

Status unknown NA Last updated 10 March 2023

What this trial tests

NA trial testing Blood pressure cuff inflation in Aortic Valve Stenosis in 140 participants. Status unknown.

Timeline

11 April 2014

Primary endpoint
1 July 2020

1 December 2024

Quick facts

Lead sponsor	Laval University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	140
Start date	11 April 2014
Primary completion	1 July 2020
Estimated completion	1 December 2024
Sites	1 location across Canada

Drugs / interventions tested

Blood pressure cuff inflation

Conditions studied

Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
Cardiopulmonary Bypass — all drugs for Cardiopulmonary Bypass →

Sponsor

Laval University

Who can join

18 and older, any sex, with Aortic Valve Stenosis or Cardiopulmonary Bypass. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study objective is to verify if a non-invasive remote ischemic preconditioning procedure (blood pressure cuff on the arm) is cardioprotective when applied before an aortic valve replacement surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.
Billah M, Ridiandries A, Allahwala U, Mudaliar H, et al · · 2019 · cited 37× · PMID 30719216 · DOI 10.18632/oncotarget.26537

Verify or expand the search:

Other recruiting trials for Aortic Valve Stenosis

Currently open trials in the same condition.

NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
NCT07520656 — Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing · recruiting
NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting

Other Laval University trials

Trials by the same sponsor.

NCT07491887 — Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption · NA · not yet recruiting
NCT07366827 — Effectiveness of Motorised Lumbar Support for Non-specific Low Back Pain · NA · not yet recruiting
NCT07317973 — A Study About Patient Decision Aids Designed to Help Parents and Guardians in Canada Make Evidence-informed, Values-cong · NA · not yet recruiting
NCT07293312 — Optimizing the Use of Virtual Reality in Rehabilitation for Individuals With Persistent Shoulder Pain · NA · not yet recruiting
NCT07201870 — Digital Preparation for Bariatric Surgery: Feasability Pilot Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03305094 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laval University
Last refreshed: 10 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03305094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing